Starlake Bioscience Co Inc Zhaoqing Guangdong (600866) — Cash Flow Reinvestment Rate
Starlake Bioscience Co Inc Zhaoqing Guangdong (600866) has a Cash Flow Reinvestment Rate of 0.52x as of September 2025, reinvesting CN¥652.49 Million (capex CN¥652.49 Million ) from operating cash flow of CN¥1.25 Billion. Check Starlake Bioscience Co Inc Zhaoqing Guan cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Starlake Bioscience Co Inc Zhaoqing Guangdong Cash Flow Reinvestment Rate (1998–2025)
Historical reinvestment intensity for Starlake Bioscience Co Inc Zhaoqing Guangdong across 25 annual periods. Explore investment intensity of Starlake Bioscience Co Inc Zhaoqing Guan to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Starlake Bioscience Co Inc Zhaoqing Guangdong (1998–2025)
Year-by-year capital reinvestment analysis for Starlake Bioscience Co Inc Zhaoqing Guangdong. For live market cap and broader valuation context, see Starlake Bioscience Co Inc Zhaoqing Guan stock valuation.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.67x | CN¥2.16 Billion | CN¥1.29 Billion | CN¥2.04 Billion | ▲ +358.2% |
| 2024 | 0.36x | CN¥873.65 Million | CN¥2.40 Billion | CN¥638.50 Million | ▼ -40.2% |
| 2023 | 0.61x | CN¥1.23 Billion | CN¥2.03 Billion | CN¥375.83 Million | ▲ +26.3% |
| 2022 | 0.48x | CN¥802.34 Million | CN¥1.66 Billion | CN¥452.34 Million | ▼ -57.0% |
| 2021 | 1.12x | CN¥216.26 Million | CN¥192.63 Million | CN¥205.08 Million | ▼ -6.8% |
| 2020 | 1.20x | CN¥301.07 Million | CN¥249.99 Million | CN¥289.89 Million | ▲ +52.3% |
| 2019 | 0.79x | CN¥168.59 Million | CN¥213.17 Million | CN¥157.41 Million | ▲ +16.3% |
| 2018 | 0.68x | CN¥34.46 Million | CN¥50.69 Million | CN¥33.71 Million | ▼ -83.6% |
| 2017 | 4.14x | CN¥165.61 Million | CN¥40.05 Million | CN¥40.61 Million | ▲ +158.8% |
| 2016 | 1.60x | CN¥65.78 Million | CN¥41.17 Million | CN¥40.26 Million | ▼ -97.9% |
| 2015 | 75.72x | CN¥207.87 Million | CN¥2.75 Million | CN¥103.49 Million | ▲ +480.4% |
| 2011 | 13.05x | CN¥859.52 Million | CN¥65.88 Million | CN¥859.52 Million | ▲ +244.3% |
| 2010 | 3.79x | CN¥396.40 Million | CN¥104.63 Million | CN¥396.40 Million | ▲ +1816.9% |
| 2009 | 0.20x | CN¥62.60 Million | CN¥316.73 Million | CN¥62.60 Million | ▼ -41.1% |
| 2008 | 0.34x | CN¥49.97 Million | CN¥148.93 Million | CN¥49.97 Million | ▼ -63.1% |
| 2007 | 0.91x | CN¥74.90 Million | CN¥82.28 Million | CN¥74.90 Million | ▼ -58.6% |
| 2006 | 2.20x | CN¥77.37 Million | CN¥35.14 Million | CN¥77.37 Million | ▲ +47.8% |
| 2005 | 1.49x | CN¥69.77 Million | CN¥46.83 Million | CN¥69.77 Million | ▼ -80.4% |
| 2004 | 7.60x | CN¥220.76 Million | CN¥29.05 Million | CN¥220.76 Million | ▲ +932.9% |
| 2003 | 0.74x | CN¥110.12 Million | CN¥149.70 Million | CN¥110.12 Million | ▲ +52.8% |
| 2002 | 0.48x | CN¥88.18 Million | CN¥183.18 Million | CN¥88.18 Million | ▼ -62.1% |
| 2001 | 1.27x | CN¥77.35 Million | CN¥60.82 Million | CN¥77.35 Million | ▲ +76.9% |
| 2000 | 0.72x | CN¥67.16 Million | CN¥93.41 Million | CN¥67.16 Million | ▼ -52.1% |
| 1999 | 1.50x | CN¥79.45 Million | CN¥52.97 Million | CN¥79.45 Million | ▼ -6.2% |
| 1998 | 1.60x | CN¥113.73 Million | CN¥71.14 Million | CN¥113.73 Million | — |